References
*As compared to Angio-Seal‡, ExoSeal‡, FemoSeal‡, InClosure‡, MANTA‡, Mynx‡, PerQseal‡, Vascade‡, Velox CD‡, X-Seal‡. Data on file at Abbott.
- Baim, Donald S., et al. “Suture-mediated closure of the femoral access site after cardiac catheterization: results of the suture to ambulate and discharge (STAND I and STAND II) trials.” American Journal of Cardiology 85.7 (2000): 864-869.
- Perclose ProGlide Versus Surgical Closure Outcomes - Real World Evidence. Schneider, Darren B; Krajcer, Zvonimir; et al. LINC 2018
- The Use of the Perclose ProGlide Suture Mediated Closure (SMC) Device for Venous Access-Site Closure up to 24F Sheaths. Kar, Saibal; Hermiller, James; et al. CRT 2018.
- 4.Feasibility and Safety of Same Day Discharge for Patients Undergoing Atrial Fibrillation (AF) Ablation in a Community Hospital Setting. HRS 2020 Poster.
- Verma S. Same-Day Discharge for AF Ablation: What Have We Learned - EP Lab Digest - August 2020.
- Mercandetti, Michael. Wound Healing and Repair. Medscape. WebMD, 19 May 2017. Web. March 21, 2018.
- Kawashima, Hideyuki et al. “Propensity-matched comparison of percutaneous and surgical cut-down approaches in transfemoral transcatheter aortic valve implantation using a balloon-expandable valve.” EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology vol. 12,16 (2017): 1954-1961. doi:10.4244/EIJ-D-16-00408
- Taku Ishibashi et al. “Safety and utility of total percutaneous endovascular aortic repair with a single Perclose ProGlide closure device.” J Vasc Surg . 2016 Mar;63(3):585-8.
- Nelson, Peter R., et al. “A multicenter, randomized, controlled trial of totally percutaneous access versus open femoral exposure for endovascular aortic aneurysm repair (the PEVAR trial).” Journal of vascular surgery 59.5 (2014): 1181-1193.